A human lymphocyte based Ex Vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function

Pharmaceutical Research

Volumn 18, Issue 1, 2001, Pages 39-44

  Parasrampuria, D A ^a,b   Lantz, M V ^c   Benet, L Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclosporine; Flow cytometer; Multidrug resistance associated protein (MRP); P glycoprotein (P gp); Quinidine; Rhodamine 123; Tacrolimus; Verapamil; Vinblastine

Indexed keywords

CYCLOSPORIN; GLYCOPROTEIN P; INDOMETACIN; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; QUINIDINE; RHODAMINE 123; SULFINPYRAZONE; TACROLIMUS; VERAPAMIL; VINBLASTINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG TRANSPORT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; PRIORITY JOURNAL;

CALCIUM CHANNEL BLOCKERS; CELL SEPARATION; CYCLOSPORINE; ENZYME INHIBITORS; FLUORESCENT DYES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; P-GLYCOPROTEIN; QUINIDINE; RHODAMINE 123; TACROLIMUS; VERAPAMIL;

EID: 0035046689     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011070509191     Document Type: Article

References (24)

1. ABC transporters: From microorganisms to multidrug efflux systems
2. Overexpression of a transporter gene in a multidrug-resistnat human lung cancer cell line
3. Biochemistry of multidrug resistance mediated by the multidrug transporter
4. P-glycoprotein expression in normal human tissues
5. Multidrug transporters from bacteria to man: Similarities in structure and function
6. Physical-cheasdfmical properties shared by compounds that modulate multidrug resistance in human leukemic ells
7. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
8. How does Pglycoprotein recognize its substrates?
9. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
10. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells
11. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay
12. Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco- 2 monolayers and excised rat jejunum
13. Disruption of the mouse màrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
14. Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression
15. Altered expression and function of P-glycoprotein (I70 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans
16. The mechanism of ATP-dependent multidrug transport by P-glycoprotein
17. Abnormal expression of a 170-kilodalton Pglycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection
18. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes
19. + cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833
20. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein
21. Calcein accumulation as a flurometric functional assay of the multidrug transporter
22. Grapefruit juice activates P-glycoprotein-mediated drug transport
23. Enhanced 9-(2phosphonylmethoxyethyl) adeninyl) adenine-esistant human erythroleukemia K 562 cell line
24. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco- 2 monolayers